Skip to Content

Picato Approval History

  • FDA approved: Yes (First approved January 23rd, 2012)
  • Brand name: Picato
  • Generic name: ingenol mebutate
  • Dosage form: Topical Gel
  • Company: Leo Pharma
  • Treatment for: Keratosis

Picato (ingenol mebutate) is an inducer of cell death indicated for the topical treatment of actinic keratosis.

Development History and FDA Approval Process for Picato

Jan 25, 2012Approval FDA Approves Picato (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.